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SUMMARY.-Continuous temperature monitoring was carried out with
thermistor probes implanted in breast tumours and in normal breast tissue.
The results indicate that an initial rise in tumour temperature induced by the
administration of nor-ethisterone acetate is associated with a subsequent
objective response to that agent, whilst a fall has the reverse implication.
Circadianrhythm has been demonstrated in all of the normal breasts and in all
the tumours.
It is suggested that skin temperature measurements above the tumour do
not accurately relate to temperature within the tumour unless there is skin
involvement.
Considerable variation with time has been demonstrated in the tumour-
normal temperature differential. This casts doubts upon the diagnostic
value of the
" normal
11 thermogram when taken as an isolated measurement.
It may also tend to obscure any relationship between the degree of tumour
temperature elevation and prognosis.
We have now extended this investigation to include the effect of radiation
to the cervix on temperature patterns in that site.
MANY therapeutic agents are available for the palliative treatment ofpatients
suffering from advanced breast cancer, each of which may produce a worthwhile
response in somepatients but not in others. Atpresent no effective method exists
for selection ofthe optimum agent for aparticularpatient, and as a result ofthis,
many are subjected to useless and often unpleasant therapeutic procedures.
It is widely recognized that tumour temperatures often differ from those. of
surrounding tissues, this being the basis of thermographic diagnosis of breast
cancer. Because these differences are caused by the presence of the neoplasm it
seems reasonable to suggest that remission or exacerbation of the disease might
result in temperature changes and that these might be detectable before the
clinical picture altered, it was therefore felt that accurate monitoring of tumour
temperature before and during trial administration of various therapeutic agents
might provide a criterion whereby the optimum treatment could be quickly
selected.
MATERIAL AND METHODS
(a) Basic considerations
Because ofthe knowncyclic variation in basicbodytemperature we considered
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implanting the monitoring probes within the tissue would eliminate any effect
of surface cooling or temperature variations due to the insulating properties of
subcutaneous fat, and would give more direct and reliable information regarding
the site of interest.
As a first phase in this work it was decided to restrict the investigation to one
therapeutic agent, nor-ethisterone acetate (SH420) (Schering, Berlin) and endea-
vour to correlate any abnormal changes in temperature patterns with subsequent
response.
(b) Monitoring8ySteln
This consisted ofsix miniature thermistorprobes designed for tissue implanta-
tion. Thermistors are constructed from semi-conducting ceramic material which
has a high negative temperature coefficient of resistance, thus providing highly
sensitive temperature sensors which can be of very small dimensions. Each
probe and its supply leads were sheathed in polythene, the total diameter being
0-024 inches. The leads ran to bedside jack points and concealed wiring trans-
mitted the signals to remote monitoring equipment. The signal from each probe
was switched in turn through matched telethermometer input circuits to a chart
recorder. Preliminaryexperiments indicated that hourly sampling ofeach probe
was adequate. The system was highly stable and repeatable measurements to
within ± 0-V F. could be consistently obtained.
(c) Probe siting and implantation
The probes were sited as follows: one, to measure body core temperature,
was sealed in the externalauditory meatusby aninsulatingplug; one wasimplan-
ted in normal breasttissue; one wasstrapped to the skinoverlying the tumour and
was covered with an insulating material and three were implanted in the tumour.
The tumour probes were implanted peripherally as early work suggested that the
tumour centre was at a lower temperature. The probes were inserted under local
anaesthesia through a small skin incision to a depth of 1-0-1-5 cm., care being
taken to minimize trauma. Initially fine forceps were used to place the probes
in position, but we now use a Trocar with slotted outer sheath to permit its
withdrawal while leaving the probes in situ. A single skin suture tied round the
polythene probe sheath maintained probe stability. Room temperature was
also recorded throughout the experiment and found to remain constant to within
approximately 3' C. during any 24-hour period.
(d) Selection ofpatients
For inclusion in the trial we required evidence of active breast cancer on the
chest wall in a patient judged incurable by current techniques and who had not
received endocrine or radiation therapy. The extent of disease was assessed
objectively; visible lesions werephotographed, radiology ofthe chest and skeleton
performed, and liver function assessed by both biochemical and radioisotope
scanning techniques.
(e) Monitoring regime
The firstthreepatients were monitoredfor6dayswithoutanysystemictherapy, each probe being sampled every 4 minutes. From the information obtained it87 TEMPERATURE CHANGES IN TUMOUR
was apVarent that hourly sampling would be adequate. The following regime
was then adopted:
i. 0-48 hours-Normal period.
ii. 48-120 hours-Test period, during which SH420, 10 mg. q.i.d. was given
orally.
iii. The patient was discharged, SH420 being continued, and subsequent
progress was recorded monthly.
RESULTS
The recorder output data for each patient were replotted using a condensed
time scale of I cm. equal to 2 hours and these graphs were inspected in relation
to the patient's subsequent response. While it is planned to use more sophistica-
ted methods of trace analysis when sufficient data have been accumulated, we
are atpresentexamining therecordings inonly two ways. First, visualinspection
ofthe patterns and differences between the various probes, and secondly, calcula-
tion of the mean temperatures in different sites for the periods before and after
administration of nor-ethisterone acetate. The post therapy mean temperatures
were calculated usingreadings starting 12 hours after the first dose to allow some
time for any hormonally produced effect to occur.
TABLEL-Mean Tumour Temperatures Before and During Nor-ethisterone
Acetate Therapy andSubsequent Rmponse to thi8Treatment
Tumour temp. 'F. Changein Patient tumour Subsequent
number Before SH420 During SH420 temp. response
4 98-30 98-45 +0-15 +ve
8 97-57 97-60 +0-03 +ve
19 98-30 98-60 +0-30 +ve
9 98-35 98-42 +0-07 +ve
5 99-45 99-00 -0-45 -ve
6 99-15 98-90 -0-25 -ve
12 98-87 98-60 -0-27 -ve
13 99-60 99-00 -0-60 -ve
17 98-92 98-85 -0-07 -ve
20 99-44 99-15 -0-29 -ve
The mean tumour temperatures before andduring therapy are shown in Table
1, as are the assessments of response. For only 10 of our patients has sufficient
time elapsed to permit unequivocal assessment, but the results do indicate that a
rise in tumourtemperature appears to be related to asubsequent response, while a
fall suggests that the patient will not benefit from the treatment.
Because ofthe small numbers in our series to date the statistical analysis used
was an exactprobability determination based on a 2 x 2 contingency table. The
probability of obtaining the observed results was found significant at the I%
level (P
== 0-0048).
The fact that such a simple single parameter provides an indication of sub-
sequent response isextremelyencouraging and it ishoped that more sophisticated
analysis using some combination of several parameters as a discriminant function
will prove to be even more definitive, perhaps enabling the degree or duration of
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Inspection of the traces has revealed several other interesting feature.:
1. In allpatients the tumourtemperature was at all times greater than that of
normal breast tissue (Fig. 1).
2. All probes implanted peripherally in the tumour showed very similar
results (Fig. 2). We suspect that the centralregion of a large tumour may
be colder than its periphery, but have not performed sufficient central
measurements to confirm this.
3. The difference in temperature between tumour and normal tissue in any
one patient varied considerably throughout any 24-hour period. The
maximum difference varied from 1.14' F. in one patient to 8-14' F. in
another. This variation is clearly shown in Fig. I where at 38 hours the
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FIG. I.-Recording illustrates tumour temperature is at all times higher than that of normal
breast tissue; this was typical of all patients in the series.
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FiG. 2.-Typical recording illustrating that the thxee independent probes implanted in
the tumour exhibited similar temperatures.0.
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difference between tumour and normal tissue is 2
-3' F. and approximately
6 hours later has reduced to 0.25' F.
4. Allpatients exhibited a cyclic temperature variation both in tumour and in
normal breast both before and during therapy (Fig. 3). Theperiod ofthis
cycling was approxi'mately 24 hours in all cases and the cycles in tumour
and normal breast were in phase. On visual inspection no correlation has
yet been observed between either period or amplitude and subsequent
response.
5. Temperature changes in normal breast tissue appear to be unrelated to
response.
6. Skin temperature measurements directly over the tumour in some cases do,
and in other do not, correlate with the results of the implanted probes.
Only in cases where the tumour actuaRy involves the skin are the results
comparable (Fig. 4).
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FIG. 3.-In all patients tested a eireadian rhythm was observed in both tumour and normal
tissue, both before and during therapy. In the traces shown, short term fluctuations have
been smoothed byapplying a 10 term moving average technique, this method hasproved of
value in enabling circadian rhythm to be directly recognized.I .. * # 1. In A * an 4m
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FiG. 4(a).-Tumour did not involve the skin. The surface probe placed directly above does
not accurately reflect tumour temperature (smoothed data).
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FIG. 4(b).-Tumour involved the skin. In this case the implanted probes and the surface
probe gave similar results. (This trace is the smoothed version of that shown in Fig. 2 and
illustrates the effect of the smoothing technique.)
DISCUSSION
There have been several attempts to enable the effectiveness of therapeutic
agents to be predicted.
In patients suffering from cancer of the uterine cervix, Graham (1947), Graham and Graham (1956) and Gilmore and co-workers (1949) attempted to
select patients suitable for surgery rather than radiation therapy on the basis
of cell changes before and after trial irradiation.
Radioisotope methods have been explored by Hale (1961) and Bunen et al.
(1963) using phosphorus-32. All these workers proposed that variations in the
32P uptake pattern in tumour induced by hormone administration might reflect
changes in tumour activity.91 TEMPERATURE CHANGES IN TUMOUR
Edelstyn and co-workers (1968) proposed certain methods ofselectingpatients
likelyto benefitfromhypophysectomy.
All these methods leave much uncertainty and none have gained general
acceptance.
Lloyd-Williams (1964) investigated a small number of patients with breast
cancer taking isolatedthermographic recordings at daily intervals and found that
in certain instances hormone administrationproduced arise in tumourtemperature
whilst in other instances a fall was noted. Where temperature fell clinical
regression occurred, and when it rose the disease seemed to be exacerbated. He
does, however, state that environmental conditions were open to criticism.
Mansfield eat al. (1968) developed this technique further, carrying out continu-
ousmonitoring oftemperature over aperiod of some 10 to 14daysusing thermistor
probes fixed to the skin. His principal finding was that in patients subsequently
showing a favourable response the most important change in the tumour tempera-
ture pattern was production or accentuation of a normal cireadian rhythm. A
fall in tumour temperature, as observed by Lloyd-Williams (1964) was also noted
in this group. Our results su-a-aest that measurements taken from the skin over-
lying the tumour may not reflect tumour temperature changes as accurately as
implanted probes. Dodd and co-workers (1969) suggested that there may be no
direct relationship between the area ofincreased heat emission and the location of
the tumour, and that not all cancers produce enough heat to result in surface
temperature gradients sufficiently pronounced to give a positive thermograph.
Unless there is skin involvement the transfer ofheat from tumour to skin surface is
mainly by venous convection, direct conduction is probably a small factor due to
the excellent insulating properties ofbody fat.
The technique we adopted could be criticized on the grounds that trauma will
be caused by implanting the probes and that different probe positions within the
tumour might give differing results due to the small volume of tissue being moni-
tored and that the impossibility ofimplanting every probe in the same relation to
neighbouring vascular structure. However, the small dimensions of the probes
and the implantation technique adopted should minimize trauma, and results
from multiple probes being implanted in the same tumour have shown that,
provided the central tumourregion is avoided, reasonably consistent temperatures
and patterns will be obtained.
Our finding that marked variations occur in the tumour-normal differential
within short times casts considerable doubt on the value of the
" normal
"
thermogram. The thermogram seems to be gaining wide acceptance as a method
ofscreening for breast cancer and involves taking an isolated measurement on the
surface temperature pattern over the breasts. Our data would further suggest
thatthe correlationbetweendegree oftumourtemperature elevationandprognosis,
proposed by Lawson and Gaston (1964) and Lloyd-Williams (1964), could be
stronger ifpeak values of elevation were used rather than isolated measurements
at an unknownposition on the temperature cycle. The results ofMansfield et al.,
(1968) and ofLloyd-Williams also exhibited this varying differential.
It is of interest that the temperature changes observed in our patients were
contradictory to those of Mansfield and Lloyd-Williams. All patients failing to
respond exhibited a slight but definite fall in mean tumour temperature on pre-
liminary hormone administration, whilst all responders showed a rise. At this
stage we would neither attempt to explain these results nor to draw very firm92 P. J. GILLESPIE, B. D. BURROWS AND G. A. EDELSTYN
conclusions; however, the subject clearly requires further investigation under
rigorouslycontrolled conditionsand asthenumberofpatientsin ourseriesincreases
we hope soon to be in a position to make a more confident assessment of this
technique.
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Note added inproof: Results up to March 1971 are as follows: In 18 out of 22 patients
an increase in tumour temperature on SH420 administration has implied a
subsequent response and a decrease a lack of response. In the two patients whose tumour temperature fell, but who responded, a marked reduction in the
amplitude of circadian rhythm was noted.